Evogene Ltd.(EVGN) stock price and fundamentals

Biotechnology · Rehovot, HM

$0.40-0.02 (-4.99%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Evogene Ltd.

Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artificial intelligence, is engineered to digitally identify and strategically guide the creation of life-science solutions derived from microbes, small molecules, and genetic components. The company's operations are structured into three primary divisions: Agriculture, Human Health, and Industrial Applications. Within the Agriculture division, Evogene works on seed traits, agricultural chemicals, and biological products aimed at improving plant yields, with efforts spanning critical crops like corn, soybean, wheat, rice, and cotton. The Industrial Applications segment focuses on enhancing castor bean seeds for use as a raw material in various industrial applications. Meanwhile, the Human Health segment is dedicated to uncovering and developing human microbiome-based treatments for conditions including immuno-oncology, gastrointestinal disorders, and antimicrobial-resistant infections. Beyond these core areas, Evogene also delivers medical cannabis products. The company maintains a global presence, conducting operations in the United States, Israel, Brazil, and other international markets. It has forged key partnerships and licensing agreements with leading agricultural enterprises, such as BASF SE, Corteva, and Bayer. Additionally, its subsidiary, Canonic Ltd., collaborates with Cannbit Ltd. on the development of innovative medical cannabis offerings. Established in 1999, Evogene Ltd. is based in Rehovot, Israel.

Rehovot, HM

52 employees

www.evogene.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ofer Haviv

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1EVGN	$3.48M	$0.40	-4.99%	-64.71%	-56.46%	-39.70%	N/A
2ICCM	$3.47M	$1.54	-1.91%	-94.60%	-63.05%	N/A	vs EVGN
3AEMD	$3.44M	$6.53	+1.16%	-83.19%	-78.27%	-65.74%	vs EVGN
4CVKD	$3.37M	$0.95	+0.60%	-93.24%	N/A	N/A	vs EVGN
5EOCN	$3.59M	$3.45	-4.43%	N/A	N/A	N/A	vs EVGN
6ADGM	$3.13M	$0.14	-7.84%	-92.86%	N/A	N/A	vs EVGN

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.19	$-0.19	$-0.19	1
Quarter ending Dec 2026	$-0.20	$-0.20	$-0.20	1

Period	Low	Avg	High	# Analysts
FY 2026	$-1.10	$-1.10	$-1.10	1
FY 2027	$-0.60	$-0.60	$-0.60	1

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$365000.00	$365000.00	$365000.00	1
Quarter ending Dec 2026	$390000.00	$390000.00	$390000.00	1

Evogene Ltd.(EVGN) stock price and fundamentals

Valuation

EVGN Price Chart

Business at a glance

EVGN Key Metrics

Total Return CAGR

EVGN Fundamental Charts

Revenue CAGR

EVGN Earnings Preview

Similar-Size Sector Stocks

EVGN Competitors' Key Metrics

EVGN Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

EVGN Analyst Ratings

EVGN Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates